medroxyprogesterone acetate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial AUST R: 12300Active ingredients:
medroxyprogesterone acetate
Dosage form:
Injection, suspension
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
02 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by an alternative presentation - DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe (ARTG 401610).
|
DEPO-RALOVERA medroxyprogesterone acetate 150 mg/1 mL injection vial AUST R: 44464Active ingredients:
medroxyprogesterone acetate
Dosage form:
Injection, suspension
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
01 Jul 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by an alternative presentation - DEPO-PROVERA medroxyprogesterone acetate 150 mg/1 mL suspension for injection pre-filled syringe (ARTG 401610).
|